Cambridge, United Kingdom

Bicycle Therapeutics Limited


USPTO Granted Patents = 8



Trademarks = 6

Forward Citations = 161

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Christian Heinis (7 out of 8 patents)

silverMedal Gregory Paul Winter (7 out of 75 patents)

bronzeMedal David Loakes (5 out of 12 patents)

4.  Elise Bernard (5 out of 5 patents)

5.  Marina Vaysburd (4 out of 4 patents)

6.  Daniel Paul Teufel (3 out of 31 patents)

7.  John Tite (2 out of 8 patents)

8.  Lutz Riechmann (2 out of 13 patents)

9.  Winter Gregory (1 out of 1 patent)

10.  Heinis Christian (1 out of 1 patent)

11.  Catherine Lucy Stace (19 patents)

12.  Edward Walker (25 patents)

13.  Christian Heinis (0 patent)

14.  Paul Gregory Winter (0 patent)

15.  John Paul Tite (0 patent)


8 patents:

Company Overview
Bicycle Therapeutics Limited is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of cancer and other debilitating diseases. The company's proprietary technology platform, Bicycle Drug Conjugates (BDCs), harnesses the natural properties of bicyclic peptides to create highly targeted therapies. With a pipeline of promising drug candidates, Bicycle Therapeutics is dedicated to advancing the field of biomedicine and improving patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#112 in Cambridge

#2,098 in United Kingdom

Cambridge, GB
Cambridge, United Kingdom
Forward Citations = 161

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bicycle Therapeutics Limited. Retrieved from https://idiyas.com/company/bicycle-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…